Omada Health, Inc. (OMDA)

Omada Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-37.62	-47.14	-67.51	-72.52
Depreciation & Amortization	5.01	4.8	4.45	4.33
Other Amortization	3.27	3.03	2.22	1.85
Loss (Gain) From Sale of Assets	0	0	0.15	0.01
Stock-Based Compensation	9.4	9.42	8.74	6.65
Provision & Write-off of Bad Debts	2.23	1.76	0.45	0.24
Other Operating Activities	0.67	0.51	3.27	-0.4
Change in Accounts Receivable	-7.04	-8.81	-5.34	-3.93
Change in Inventory	-0.07	0.32	-0.07	-1.95
Change in Accounts Payable	1.33	0.4	-0.29	-4.99
Change in Unearned Revenue	0.55	4.65	1.44	1.79
Change in Other Net Operating Assets	-7.39	-3.13	2.76	-0.06
Operating Cash Flow	-29.65	-34.18	-49.74	-68.98
Capital Expenditures	-0.73	-0.6	-0.42	-0.72
Sale (Purchase) of Intangibles	-3.6	-3.27	-2.51	-2
Investing Cash Flow	-4.33	-3.86	-2.92	-2.72
Long-Term Debt Issued	-	-	30.96	-
Long-Term Debt Repaid	-	-	-30	-
Net Debt Issued (Repaid)	-	-	0.96	-
Issuance of Common Stock	3.26	3.33	1.76	1.74
Other Financing Activities	-4.65	-4.54	-2.54	-
Financing Cash Flow	-1.39	-1.21	0.18	16.32
Net Cash Flow	-35.37	-39.25	-52.48	-55.38
Free Cash Flow	-30.38	-34.78	-50.15	-69.7
Free Cash Flow Margin	-16.02%	-20.48%	-40.85%	-78.15%
Free Cash Flow Per Share	-3.84	-4.50	-7.07	-10.28
Cash Interest Paid	3.78	3.85	4.09	3.61
Levered Free Cash Flow	-	-15.16	-29.39	-
Unlevered Free Cash Flow	-	-12.73	-26.87	-
Change in Net Working Capital	-	-1.55	-2.31	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q